Summary
Abstract
Introduction
Protocol
Representative Results
Discussion
Acknowledgements
Materials
References
Immunology and Infection
This co-immunoprecipitation protocol allows to study the interaction between the influenza A virus nucleoprotein and the antiviral Mx1 protein in human cells. The protocol emphasizes the importance of N-ethylmaleimide for successful co-immunoprecipitation of Mx1 and influenza A virus nucleoprotein.
Studying the interaction between proteins is key in understanding their function(s). A very powerful method that is frequently used to study interactions of proteins with other macromolecules in a complex sample is called co-immunoprecipitation. The described co-immunoprecipitation protocol allows to demonstrate and further investigate the interaction between the antiviral myxovirus resistance protein 1 (Mx1) and one of its viral targets, the influenza A virus nucleoprotein (NP). The protocol starts with transfected mammalian cells, but it is also possible to use influenza A virus infected cells as starting material. After cell lysis, the viral NP protein is pulled-down with a specific antibody and the resulting immune-complexes are precipitated with protein G beads. The successful pull-down of NP and the co-immunoprecipitation of the antiviral Mx1 protein are subsequently revealed by western blotting. A prerequisite for successful co-immunoprecipitation of Mx1 with NP is the presence of N-ethylmaleimide (NEM) in the cell lysis buffer. NEM alkylates free thiol groups. Presumably this reaction stabilizes the weak and/or transient NP–Mx1 interaction by preserving a specific conformation of Mx1, its viral target or an unknown third component. An important limitation of co-immunoprecipitation experiments is the inadvertent pull-down of contaminating proteins, caused by nonspecific binding of proteins to the protein G beads or antibodies. Therefore, it is very important to include control settings to exclude false positive results. The described co-immunoprecipitation protocol can be used to study the interaction of Mx proteins from different vertebrate species with viral proteins, any pair of proteins, or of a protein with other macromolecules. The beneficial role of NEM to stabilize weak and/or transient interactions needs to be tested for each interaction pair individually.
Myxovirus modstand (Mx) proteiner er en vigtig del af det medfødte immunforsvar mod virale patogener. Disse proteiner er store dynamin-lignende GTPaser, der induceres af type I og type III interferoner. De tilsvarende Mx gener er til stede i næsten alle hvirveldyr i en eller flere kopier og deres genprodukter inhibere en bred vifte af vira, herunder Orthomyxoviridae (f.eks., Influenza virus), Rhabdoviridae (f.eks., Vesikulær stomatitis virus), Bunyaviridae (f.eks. , La Crosse-virus) og Retroviridae (fx humant immundefektvirus-1) 1-4. Det er uklart, hvordan disse proteiner genkender en så bred vifte af vira, uden nogen ti....
Bemærk: Følgende transfektion og co-immunopræcipitering protokol er udfærdiget til en 9 cm petriskål format. Andre formater er også muligt efter skalering protokollen.
1. podning af den humane embryonale nyre (HEK) 293T-celler
N-ethylmaleimid er en organisk forbindelse, der kan anvendes til irreversibelt at ændre frie thiolgrupper, fx at inhibere cysteinproteaser (figur 1).
Den antivirale Mx1 protein inhiberer influenza A virus replikation ved at interagere med den virale nukleoprotein. Den optimerede co-immunpræcipitering protokollen beskrevet her tillader at undersøge dette NP-Mx1 interaktion. HEK293T celler blev transficeret med ekspressionsvektorer for den antivirale Mx1 protein i .......
Studer interaktionen mellem antivirale proteiner og deres virale mål er meget vigtigt at forstå detaljerne i den antivirale mekanisme af disse proteiner. Dette kan give ny indsigt i, hvordan vira og deres værter co-udviklet og danne grundlag for udvikling af nye antivirale strategier. Den optimerede co-immunpræcipitering protokollen beskrevet her tillader at studere interaktionen mellem muse Mx1 protein og dets virale mål, influenza NP protein. Det vigtigste aspekt af denne protokol er tilsætningen af NEM i lysepu.......
Name | Company | Catalog Number | Comments |
DMEM high glucose | Gibco | 52100-047 | |
N-Ethylmaleimide | Sigma | E-3876 | Toxic |
Igepal CA-630 | Sigma | I-30212 | also known as NP40 |
Protease Inhibitor Cocktail | Roche | 11 873 580 001 | |
anti-NP monoclonal antibody | NIH Biodefense and Emerging Infections Research Resources Repository | NR-4282 | ascites blend of clones A1 and A3 |
anti-RNP polyclonal serum | NIH Biodefense and Emerging Infections Research Resources Repository | NR-3133 | directed against A/Scotland/840/74 (H3N2) |
Protein G Sepharose 4FF | GE Healthcare | 17-0618-01 | |
Hyperfilm ECL 18 x 24 cm | GE Healthcare | 28-9068-36 | |
ECL Western Blotting Substrate | Pierce | 32106 |
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved